Yan Shu, MD, PhD
Professor of Pharmaceutical Sciences
University of Maryland School of Pharmacy
YA6060, A Novel Small Molecule to Treat Human Cancer and Metabolic Diseases
YA6060 is a new molecule that impacts two key signaling pathways (Wnt & AMPK) exploited by many cancer cells. This project will evaluate its effects against a challenging preclinical model of colon cancer, the 2nd most lethal cancer in the U.S.
For more information about this technology, please contact the UM Ventures, Baltimore team.
Bio
Dr. Yan Shu is a professor in the Department of Pharmaceutical Sciences. He received his medical degrees (MB/MD) from Hunan Medical University (now Xiang Yia Medical School, Central South University) in China. He then completed a clinical pharmacology fellowship between 2000 and 2002 in the University of California San Francisco, where he later received his PhD degree in Pharmaceutical Sciences & Pharmacogenomics in 2006. He worked at Cedars-Sinai Medical Center at Los Angeles as a faculty scientist in 2007. He joined the University of Maryland School of Pharmacy in 2008.